HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qi Lu Selected Research

MicroRNAs (MicroRNA)

5/2024HPV16-miRNAs exert oncogenic effects through enhancers in human cervical cancer.
1/2021MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
1/2021Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network.
1/2017MicroRNA-873 is a Potential Serum Biomarker for the Detection of Ectopic Pregnancy.
7/2009MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qi Lu Research Topics

Disease

48Neoplasms (Cancer)
05/2024 - 08/2004
41Wounds and Injuries (Trauma)
12/2022 - 01/2002
40Shock
10/2021 - 01/2002
31Hemorrhagic Shock
07/2014 - 01/2002
27Lung Injury
12/2011 - 06/2002
23Inflammation (Inflammations)
06/2024 - 08/2002
18Type 2 Diabetes Mellitus (MODY)
03/2024 - 01/2022
12Cardiovascular Diseases (Cardiovascular Disease)
04/2024 - 03/2012
11Breast Neoplasms (Breast Cancer)
01/2022 - 01/2018
10Neoplasm Metastasis (Metastasis)
01/2024 - 08/2004
9Hemorrhage
12/2022 - 08/2005
8Stroke (Strokes)
04/2024 - 01/2009
7Infections
10/2021 - 05/2012
7Ischemia
01/2021 - 09/2004
6Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2024 - 08/2013
6Heart Failure
04/2024 - 06/2020
6Insulin Resistance
03/2024 - 01/2020
5Hypertension (High Blood Pressure)
06/2024 - 12/2016
5Ovarian Neoplasms (Ovarian Cancer)
04/2024 - 05/2016
5Hypoxia (Hypoxemia)
10/2023 - 09/2004
4Carcinogenesis
10/2023 - 08/2004
4Prediabetic State (Prediabetes)
07/2023 - 01/2021
4Body Weight (Weight, Body)
12/2022 - 06/2010
4Sepsis (Septicemia)
01/2021 - 05/2006
4Blindness (Hysterical Blindness)
01/2021 - 11/2015
4Reperfusion Injury
12/2017 - 09/2004
4Burns
07/2014 - 11/2003
3Circulating Neoplastic Cells
04/2024 - 01/2019
3Diabetic Retinopathy (Retinopathy, Diabetic)
04/2024 - 01/2023
3Myocardial Ischemia (Ischemic Heart Diseases)
04/2024 - 12/2017
3Myocardial Infarction
04/2024 - 03/2015
3Chronic Renal Insufficiency
04/2024 - 09/2023
3Mitochondrial Diseases (Mitochondrial Disease)
03/2024 - 05/2020
3Cardiotoxicity
02/2024 - 01/2022
3Hepatocellular Carcinoma (Hepatoma)
01/2024 - 06/2020
3Melanoma (Melanoma, Malignant)
11/2023 - 01/2022
3Atherosclerosis
09/2023 - 06/2020
3Diabetic Neuropathies (Diabetic Neuropathy)
01/2023 - 11/2021
3Hemophilia B (Haemophilia B)
12/2022 - 03/2010
3Alzheimer Disease (Alzheimer's Disease)
12/2022 - 01/2020
3Gestational Diabetes (Gestational Diabetes Mellitus)
08/2022 - 01/2022
3Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 04/2018
3Hypertrophy
01/2022 - 04/2015
3Hemophilia A (Haemophilia)
01/2020 - 05/2015
3Hyperalgesia
01/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

36salicylhydroxamic acid (SHAM)IBA
07/2014 - 01/2002
25Proteins (Proteins, Gene)FDA Link
01/2024 - 09/2004
18Biomarkers (Surrogate Marker)IBA
06/2024 - 01/2015
10Peroxidase (Myeloperoxidase)IBA
01/2022 - 11/2004
9CytokinesIBA
10/2023 - 07/2004
7hydroxide ionIBA
04/2024 - 01/2021
7LipidsIBA
03/2024 - 05/2005
6C-Reactive ProteinIBA
03/2024 - 05/2015
6Evans Blue (Blue, Evans)FDA Link
01/2021 - 11/2004
5HDL LipoproteinsIBA
06/2024 - 06/2020
5Lipoproteins (Lipoprotein)IBA
06/2024 - 10/2022
5MicroRNAs (MicroRNA)IBA
05/2024 - 07/2009
525-hydroxyvitamin DIBA
04/2024 - 01/2021
5Glucose (Dextrose)FDA LinkGeneric
04/2024 - 01/2022
5Peptide Hydrolases (Proteases)FDA Link
11/2023 - 11/2004
5Vitamin DFDA LinkGeneric
11/2023 - 01/2022
5Retinaldehyde (Retinal)IBA
01/2023 - 11/2015
5Ringer's LactateIBA
08/2008 - 06/2002
4Triglycerides (Triacylglycerol)IBA
06/2024 - 01/2021
4Small Interfering RNA (siRNA)IBA
04/2024 - 11/2020
4CarbohydratesIBA
03/2024 - 06/2020
4Doxorubicin (Adriamycin)FDA LinkGeneric
03/2024 - 01/2022
4Long Noncoding RNAIBA
01/2024 - 01/2021
4AntioxidantsIBA
11/2023 - 07/2019
4CateninsIBA
01/2023 - 01/2018
4Peptides (Polypeptides)IBA
12/2022 - 12/2005
4Factor IX (Coagulation Factor IX)FDA LinkGeneric
12/2022 - 03/2010
4AlbuminsIBA
01/2022 - 08/2004
4Phenobarbital (Luminal)FDA Link
01/2021 - 02/2010
4Interleukin-6 (Interleukin 6)IBA
01/2019 - 06/2002
4Coloring Agents (Dyes)IBA
01/2011 - 11/2004
4Gonadal Steroid Hormones (Sex Hormones)IBA
02/2010 - 11/2003
3Fatty Acids (Saturated Fatty Acids)IBA
06/2024 - 01/2023
3Amino AcidsFDA Link
06/2024 - 01/2023
3AnthracyclinesIBA
03/2024 - 01/2020
3Insulin (Novolin)FDA Link
02/2024 - 01/2021
3Ethanol (Ethyl Alcohol)IBA
02/2024 - 01/2020
3AntigensIBA
10/2023 - 06/2020
3IronIBA
10/2023 - 03/2018
3GoldIBA
08/2023 - 04/2017
3Reactive Oxygen Species (Oxygen Radicals)IBA
08/2023 - 05/2020
3Lactic Acid (Lactate)FDA LinkGeneric
01/2023 - 01/2021
3SincalideFDA Link
10/2022 - 01/2018
3LipopolysaccharidesIBA
09/2022 - 09/2004
3Hemoglobins (Hemoglobin)IBA
01/2021 - 02/2017
3Factor VIII (Coagulation Factor VIII)IBA
01/2020 - 05/2015

Therapy/Procedure

22Therapeutics
11/2023 - 06/2002
22Laparotomy
05/2016 - 06/2002
16Resuscitation
12/2011 - 01/2002
11Drug Therapy (Chemotherapy)
03/2024 - 03/2014
11Ligation
08/2011 - 06/2002
7Immunotherapy
11/2023 - 11/2020
5Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2022 - 03/2020
4Trachelectomy
01/2019 - 08/2013
3Length of Stay
01/2022 - 11/2009